SELLAS Life Sciences Group, Inc. (SLS) Earnings
NASDAQ·Healthcare·Biotechnology
$7.87
+4.44%
Mkt Cap $1.12B
EPS — Estimate vs Actual
Mkt Cap
$1.12B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.23
NASDAQ·Healthcare·Biotechnology
$7.87
+4.44%
Mkt Cap $1.12B
Mkt Cap
$1.12B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.23